Clesham K, Walf Vorderw xfc lbecke V, Gasparoli L, Virely C, Cantilena S, Tsakaneli A, et al. Identification of a c-MYB-directed therapeutic for acute myeloid leukemia. Leukemia. 2022;36:1541-1549 pubmed publisher

Adamiak M, Bujko K, Thapa A, Pensato V, Brzeźniakiewicz Janus K, Ratajczak J, et al. The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing-a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking. Leukemia. 2022;36:248-256 pubmed publisher

Mohseni M, Kucharski C, K C R, Nasrullah M, Jiang X, Uludag H, et al. Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL). PLoS ONE. 2021;16:e0251719 pubmed publisher

Thapa A, Adamiak M, Bujko K, Ratajczak J, Abdel Latif A, Kucia M, et al. Danger-associated molecular pattern molecules take unexpectedly a central stage in Nlrp3 inflammasome-caspase-1-mediated trafficking of hematopoietic stem/progenitor cells. Leukemia. 2021;35:2658-2671 pubmed publisher

Oliemuller E, Newman R, Tsang S, Foo S, Muirhead G, Noor F, et al. SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells. elife. 2020;9: pubmed publisher

Annageldiyev C, Gowda K, Patel T, Bhattacharya P, Tan S, Iyer S, et al. The novel Isatin analog KS99 targets stemness markers in acute myeloid leukemia. Haematologica. 2019;: pubmed publisher

Nakagawa Y, Ashihara E, Yao H, Yokota A, Toda Y, Miura Y, et al. Multiple myeloma cells adapted to long-exposure of hypoxia exhibit stem cell characters with TGF-β/Smad pathway activation. Biochem Biophys Res Commun. 2018;496:490-496 pubmed publisher

Adamiak M, Chelvarajan L, Lynch K, Santos W, Abdel Latif A, Ratajczak M. Mobilization studies in mice deficient in sphingosine kinase 2 support a crucial role of the plasma level of sphingosine-1-phosphate in the egress of hematopoietic stem progenitor cells. Oncotarget. 2017;8:65588-65600 pubmed publisher

Litzenburger U, Buenrostro J, Wu B, Shen Y, Sheffield N, Kathiria A, et al. Single-cell epigenomic variability reveals functional cancer heterogeneity. Genome Biol. 2017;18:15 pubmed publisher

Yang Z, Augustin J, Chang C, Hu J, Shah K, Chang C, et al. The DPY30 subunit in SET1/MLL complexes regulates the proliferation and differentiation of hematopoietic progenitor cells. Blood. 2014;124:2025-33 pubmed publisher

Lee H, Che J, Oh J, Chung S, Jung H, Park K. Bone marrow stem/progenitor cell mobilization in C57BL/6J and BALB/c mice. Lab Anim Res. 2014;30:14-20 pubmed publisher

Mangolini M, de Boer J, Walf Vorderwülbecke V, Pieters R, den Boer M, Williams O. STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia. Blood. 2013;122:542-9 pubmed publisher

Osaki H, Walf Vorderwülbecke V, Mangolini M, Zhao L, Horton S, Morrone G, et al. The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis. Leukemia. 2013;27:1461-8 pubmed publisher

Zibara K, Hamdan R, Dib L, Sindet Pedersen S, Kharfan Dabaja M, Bazarbachi A, et al. Acellular bone marrow extracts significantly enhance engraftment levels of human hematopoietic stem cells in mouse xeno-transplantation models. PLoS ONE. 2012;7:e40140 pubmed publisher

Ratajczak M, Lee H, Wysoczynski M, Wan W, Marlicz W, Laughlin M, et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization du. Leukemia. 2010;24:976-85 pubmed publisher